Inventor · disambiguated record
Penelope M. Drake
Also filed as: DRAKE PENELOPE M
10 granted patents·16 pending applications·4 citations·filing 2015–2025
80Inventor score
Top patents by PatentIndex Score
26 records- 0188US11097013B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2018·Granted Aug 24, 2021·3 cites·29 claims
- 0277US12296021B2Antibody conjugates and methods of making and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2022·Granted May 13, 2025·0 cites·13 claims
- 0376US2025223302A1Camptothecine antibody-drug conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 0474US12187745B2Camptothecine antibody-drug conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Granted Jan 7, 2025·0 cites·15 claims
- 0572US2025381290A1Antibody Conjugates and Methods of Making and Using the SameSCHERER TECHNOLOGIES LLC R P·Filed 2025·Application pending·0 cites
- 0672US2024360123A1Anti-CD25 Antibody-Maytansine Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2023·Application pending·0 cites
- 0772US2025084182A1Antibody specific for mucin-1 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 0870US11564989B2Camptothecine antibody-drug conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Granted Jan 31, 2023·0 cites·17 claims
- 0969US12076411B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2021·Granted Sep 3, 2024·0 cites·27 claims
- 1069US10124070B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2015·Granted Nov 13, 2018·1 cites·26 claims
- 1166US11970546B2Antibody specific for Mucin-1 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted Apr 30, 2024·0 cites·23 claims
- 1266US11857637B2Anti-CD25 antibody-maytansine conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted Jan 2, 2024·0 cites·22 claims
- 1366US11466096B2Antibody conjugates and methods of making and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Oct 11, 2022·0 cites·26 claims
- 1466US2025101098A1Antibodies and antibody conjugates specific for nectin-4 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1565US2024325556A1Methods of Using Antibody-Drug-ConjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1665US2025121083A1Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) Antibody-Maytansine Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1764US2025121090A1Antibody-Drug Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1860US2025295803A15t4 antibody-drug conjugates and uses thereofEXELIXIS INC·Filed 2023·Application pending·0 cites
- 1959US2025152724A1Antibody conjugates specific for mucin-1 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 2058US2024343818A1Antibodies Having Humanized Framework RegionsSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 2158US2024376509A1Methods of Controlling Cleavage of Formylglycine-Containing PolypeptidesSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 2256US2024245794A1Anti-cd37 antibody-maytansine conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 2354US2024148883A1Branched Linkers for Antibody-Drug Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 2453US2024197907A1Dual-Cleavage Ester Linkers for Antibody-Drug ConjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 2551US2023059250A1Anti-CD37 Antibody-Maytansine Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2020·Application pending·0 cites
- 2649US12102689B2Anti-CD22 antibody-maytansine conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2016·Granted Oct 1, 2024·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Penelope M. Drake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →